Pierre Kyme - 14 Mar 2025 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Business Officer
Signature
/s/ Pierre Kyme
Issuer symbol
ARMP
Transactions as of
14 Mar 2025
Transactions value $
-$2,003
Form type
4
Filing time
25 Apr 2025, 16:06:15 UTC
Previous filing
07 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Tax liability -$2K -1.03K -8.92% $1.95 10.5K 14 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.